Animi-3 is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pbm Pharmaceuticals, Inc. The primary component is Folic Acid; Cholecalciferol; Pyridoxine Hydrochloride; Cyanocobalamin; Omega-3 Fatty Acids; Doconexent; Icosapent; Soy Sterol.
| Product ID | 66213-543_5e947d00-9af4-4632-bca3-e8b30ce39100 |
| NDC | 66213-543 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Animi-3 |
| Generic Name | Folic Acid, Cholecalciferol, Pyridoxine Hydrochloride, Cyanocobalamin, Omega-3 Fatty Acids, Doconexent, Icosapent, Phytosterols |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-06-01 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | PBM Pharmaceuticals, Inc |
| Substance Name | FOLIC ACID; CHOLECALCIFEROL; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; OMEGA-3 FATTY ACIDS; DOCONEXENT; ICOSAPENT; SOY STEROL |
| Active Ingredient Strength | 1 mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2011-06-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-06-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| FOLIC ACID | 1 mg/1 |
| SPL SET ID: | 469db782-ba46-485d-b5b7-1ef32805bdb7 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ANIMI-3 76574844 2940637 Live/Registered |
PBM Pharmaceuticals, Inc. 2004-02-06 |
![]() ANIMI-3 76548928 2940632 Live/Registered |
PBM Pharmaceuticals, Inc. 2003-09-11 |